Total Payments
$2,874
2024 Payments
$42.32
Companies
22
Transactions
173
Medicare Patients
248
Medicare Billing
$20,143
Payment Breakdown by Category
Food & Beverage$2,849 (99.1%)
Education$24.90 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,849 | 170 | 99.1% |
| Education | $24.90 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $780.29 | 52 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $579.89 | 23 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $300.06 | 22 | $0 (2020) |
| Amgen Inc. | $274.50 | 14 | $0 (2020) |
| Lilly USA, LLC | $117.90 | 9 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $108.16 | 8 | $0 (2019) |
| PFIZER INC. | $99.48 | 4 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94.95 | 7 | $0 (2019) |
| Astellas Pharma US Inc | $66.80 | 4 | $0 (2019) |
| Indivior Inc. | $65.82 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.32 | 2 | Indivior Inc. ($24.58) |
| 2023 | $41.24 | 2 | Indivior Inc. ($41.24) |
| 2022 | $25.90 | 1 | Boston Scientific Corporation ($25.90) |
| 2020 | $488.18 | 36 | Novo Nordisk Inc ($141.98) |
| 2019 | $778.05 | 47 | AstraZeneca Pharmaceuticals LP ($204.25) |
| 2018 | $732.12 | 40 | Novo Nordisk Inc ($374.82) |
| 2017 | $766.25 | 45 | AstraZeneca Pharmaceuticals LP ($220.50) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Opioid Use Disorder | ||||||
| 03/06/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: OUD | ||||||
| 11/08/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: OUD | ||||||
| 10/18/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: OUD | ||||||
| 02/03/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/13/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 10/29/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/06/2020 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/29/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Central Nervous System | ||||||
| 09/25/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Neuroscience | ||||||
| 08/17/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 08/14/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Diabetes | ||||||
| 07/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 07/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 07/20/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Obesity | ||||||
| 07/09/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/02/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Diabetes | ||||||
| 07/02/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Diabetes | ||||||
| 06/25/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes | ||||||
| 05/29/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 248 | 361 | $57,530 | $20,143 |
Total Patients
248
Total Services
361
Medicare Billing
$20,143
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 149 | 254 | $36,588 | $12,964 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 49 | 49 | $14,700 | $5,647 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 42 | $5,922 | $1,416 | 23.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 16 | 16 | $320.00 | $115.82 | 36.2% |
About Dr. Gilbert Perez, M.D
Dr. Gilbert Perez, M.D is a Family Medicine healthcare provider based in Grindstone, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659575041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Perez, M.D has received a total of $2,874 in payments from pharmaceutical and medical device companies, with $42.32 received in 2024. These payments were reported across 173 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,849).
As a Medicare-enrolled provider, Perez has provided services to 248 Medicare beneficiaries, totaling 361 services with total Medicare billing of $20,143. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Grindstone, PA
- Active Since 06/12/2007
- Last Updated 07/02/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1659575041
Products in Payments
- FARXIGA (Drug) $483.69
- Ozempic (Drug) $378.68
- Victoza (Drug) $308.68
- XARELTO (Drug) $265.49
- Repatha (Biological) $167.59
- ELIQUIS (Drug) $106.83
- ENTRESTO (Drug) $93.67
- BEVESPI AEROSPHERE (Drug) $91.20
- Aimovig (Biological) $82.70
- MYRBETRIQ (Drug) $66.80
- Tresiba (Drug) $65.96
- SUBLOCADE (Drug) $65.82
- JANUVIA (Drug) $47.59
- TRULICITY (Drug) $44.01
- Edarbyclor (Drug) $37.93
- JARDIANCE (Drug) $36.79
- INVOKANA (Drug) $34.57
- TRADJENTA (Drug) $34.14
- CHANTIX (Drug) $31.92
- ANORO (Drug) $29.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.